Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Noel Barrett

Showing results (11-20 of 66) with videos related to

Pageof 7
Sort By:
Expert Review of Vaccines|July 21, 2017
Vero cell technology for rapid development of inactivated whole virus vaccines for emerging viral diseasesP Noel Barrett, Sara J Terpening, Doris Snow, et al.
Vaccine|November 10, 2009
Comparison of single, homologous prime-boost and heterologous prime-boost immunization strategies against H5N1 influenza virus in a mouse challenge modelNicolas Sabarth, M Keith Howard, Helga Savidis-Dacho, et al.
Plos One|May 23, 2013
Quantitative detection of Borrelia burgdorferi sensu lato in erythema migrans skin lesions using internally controlled duplex real time PCRMaria O'Rourke, Andreas Traweger, Lara Lusa, et al.
Lancet (London, England)|February 19, 2011
Efficacy, safety, and immunogenicity of a Vero-cell-culture-derived trivalent influenza vaccine: a multicentre, double-blind, randomised, placebo-controlled trialP Noel Barrett, Gregory Berezuk, Sandor Fritsch, et al.
The Journal of Antimicrobial Chemotherapy|December 22, 2016
Pharmacokinetics and tolerability of ABX464, a novel first-in-class compound to treat HIV infection, in healthy HIV-uninfected subjectsDidier Scherrer, Regine Rouzier, P Noel Barrett, et al.
Vaccine|March 10, 2010
An inactivated West Nile Virus vaccine derived from a chemically synthesized cDNA systemKlaus K Orlinger, Georg W Holzer, Julia Schwaiger, et al.
Vaccine|December 20, 2011
Quantitative comparison of the cross-protection induced by tick-borne encephalitis virus vaccines based on European and Far Eastern virus subtypesRichard Fritz, Klaus K Orlinger, Yvonne Hofmeister, et al.
Plos One|August 31, 2011
H5N1 whole-virus vaccine induces neutralizing antibodies in humans which are protective in a mouse passive transfer modelM Keith Howard, Nicolas Sabarth, Helga Savidis-Dacho, et al.
Vaccine|August 17, 2011
Prevention of tick-borne encephalitis by FSME-IMMUN vaccines: review of a clinical development programmeAlexandra Loew-Baselli, Eva Maria Poellabauer, Borislava G Pavlova, et al.
Plos One|November 22, 2013
Evaluation of OspA vaccination-induced serological correlates of protection against Lyme borreliosis in a mouse modelMichael G Schwendinger, Maria O'Rourke, Andreas Traweger, et al.
Pageof 7

Showing results (11-20 of 66) with videos related to

Sort By:
Pageof 7
Expert Review of Vaccines|July 21, 2017
Vero cell technology for rapid development of inactivated whole virus vaccines for emerging viral diseasesP Noel Barrett, Sara J Terpening, Doris Snow, et al.
Vaccine|November 10, 2009
Comparison of single, homologous prime-boost and heterologous prime-boost immunization strategies against H5N1 influenza virus in a mouse challenge modelNicolas Sabarth, M Keith Howard, Helga Savidis-Dacho, et al.
Plos One|May 23, 2013
Quantitative detection of Borrelia burgdorferi sensu lato in erythema migrans skin lesions using internally controlled duplex real time PCRMaria O'Rourke, Andreas Traweger, Lara Lusa, et al.
Lancet (London, England)|February 19, 2011
Efficacy, safety, and immunogenicity of a Vero-cell-culture-derived trivalent influenza vaccine: a multicentre, double-blind, randomised, placebo-controlled trialP Noel Barrett, Gregory Berezuk, Sandor Fritsch, et al.
The Journal of Antimicrobial Chemotherapy|December 22, 2016
Pharmacokinetics and tolerability of ABX464, a novel first-in-class compound to treat HIV infection, in healthy HIV-uninfected subjectsDidier Scherrer, Regine Rouzier, P Noel Barrett, et al.
Vaccine|March 10, 2010
An inactivated West Nile Virus vaccine derived from a chemically synthesized cDNA systemKlaus K Orlinger, Georg W Holzer, Julia Schwaiger, et al.
Vaccine|December 20, 2011
Quantitative comparison of the cross-protection induced by tick-borne encephalitis virus vaccines based on European and Far Eastern virus subtypesRichard Fritz, Klaus K Orlinger, Yvonne Hofmeister, et al.
Plos One|August 31, 2011
H5N1 whole-virus vaccine induces neutralizing antibodies in humans which are protective in a mouse passive transfer modelM Keith Howard, Nicolas Sabarth, Helga Savidis-Dacho, et al.
Vaccine|August 17, 2011
Prevention of tick-borne encephalitis by FSME-IMMUN vaccines: review of a clinical development programmeAlexandra Loew-Baselli, Eva Maria Poellabauer, Borislava G Pavlova, et al.
Plos One|November 22, 2013
Evaluation of OspA vaccination-induced serological correlates of protection against Lyme borreliosis in a mouse modelMichael G Schwendinger, Maria O'Rourke, Andreas Traweger, et al.
Pageof 7